A carregar...
Maintenance Therapy with Low-Dose Azacitidine after Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed AML or MDS: a Dose and Schedule Finding Study
BACKGROUND: Recurrence is a major cause of treatment failure after allogeneic transplantation for AML and MDS, and treatment options are very limited. Azacitidine is a DNA methyltransferase inhibitor with activity in myeloid disease. We hypothesized that low-dose azacitidine administered after trans...
Na minha lista:
| Publicado no: | Cancer |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669059/ https://ncbi.nlm.nih.gov/pubmed/20672358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.25500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|